Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  12,673 results for ""Hepatocellular carcinoma""

Your Filters

Geographic : china
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Cost-effectiveness of tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma: a comparative analysis in China, the United States and Europe.

  • Authors : Sun Y; Department of Pharmaceutical Regulatory Science and Pharmacoeconomics, School of Pharmacy, Nanjing Medical University, Nanjing, 211166, Jiangsu, China.; Xu K

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/economics ; Cost-Benefit Analysis*

  • Source: International journal of clinical pharmacy [Int J Clin Pharm] 2025 Feb; Vol. 47 (1), pp. 196-209. Date of Electronic Publication: 2024 Nov 25.Publisher: Springer Country of Publication: Netherlands NLM ID: 101554912 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Lower Serum Albumin Level: A Prospective Risk Predictor of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection.

  • Authors : Song Y; Department of Interventional Radiology, The People's Hospital of Ganzhou City, Ganzhou, China.; Chen H

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/epidemiology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/blood ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/etiology

  • Source: Journal of viral hepatitis [J Viral Hepat] 2024 Dec; Vol. 31 (12), pp. 857-865. Date of Electronic Publication: 2024 Sep 16.Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 9435672 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Lenvatinib plus drug-eluting bead transarterial chemoembolization with/without hepatic arterial infusion chemotherapy for hepatocellular carcinoma larger than 7 cm with major portal vein tumor thrombosis: a multicenter retrospective cohort study.

  • Authors : Cai M; Department of Minimally Invasive Interventional Radiology, The Second Affiliated Hospital of Guangzhou Medical University.; Liang L

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology

  • Source: International journal of surgery (London, England) [Int J Surg] 2024 Dec 01; Vol. 110 (12), pp. 7860-7870. Date of Electronic Publication: 2024 Dec 01.Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 101228232 Publication Model: Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Machine learning models for predicting postoperative peritoneal metastasis after hepatocellular carcinoma rupture: a multicenter cohort study in China.

  • Authors : Xia F; Department of Hepatic Surgery, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China.; Chen Q

Subjects: Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/surgery ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/surgery

  • Source: The oncologist [Oncologist] 2025 Jan 17; Vol. 30 (1).Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition).

Subjects: Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/surgery ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/drug therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/surgery

  • Source: Bioscience trends [Biosci Trends] 2025 Jan 14; Vol. 18 (6), pp. 505-524. Date of Electronic Publication: 2024 Dec 25.Publisher: International Research and Cooperation Association for Bio & Socio-Sciences Advancement Country of Publication: Japan NLM ID: 101502754 Publication

Record details

Read More Add to Saved list
×
Academic Journal

Disease Burden Estimation of Hepatocellular Carcinoma Attributable to Dietary Aflatoxin Exposure in Sichuan Province, China.

  • Authors : Qin M; West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu 600041, China.; Chongqing Center for Disease Control and Prevention, Chongqing 400707, China.

Subjects: Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/epidemiology ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/etiology ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/chemically induced

  • Source: Nutrients [Nutrients] 2024 Dec 19; Vol. 16 (24). Date of Electronic Publication: 2024 Dec 19.Publisher: MDPI Publishing Country of Publication: Switzerland NLM ID: 101521595 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Genetic variants in folate metabolism-related genes, serum folate and hepatocellular carcinoma survival: the Guangdong Liver Cancer Cohort study.

  • Authors : Li Y; Department of Nutrition, Guangdong Provincial Key Laboratory of Food, Nutrition and Health, School of Public Health, Sun Yat-sen University, Guangzhou, People's Republic of China.; Shu J

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/genetics ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/mortality ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/blood

  • Source: The British journal of nutrition [Br J Nutr] 2024 Dec 14; Vol. 132 (11), pp. 1411-1422. Date of Electronic Publication: 2024 Nov 07.Publisher: Published on behalf of the Nutrition Society by CABI Publishing Country of Publication: England NLM ID: 0372547 Publication Model: Print-Electronic

Record details

Read More Add to Saved list
×
Academic Journal

Real-world status, efficacy and prognosis analysis of first-line treatment for unresectable hepatocellular carcinoma in patients treated at multiple centres.

  • Authors : Liu J; Department of Medical Oncology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China.; Du Q

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/blood ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/mortality ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/therapy

  • Source: Annals of medicine [Ann Med] 2024 Dec; Vol. 56 (1), pp. 2393291. Date of Electronic Publication: 2024 Aug 21.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8906388 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Epidemiological and clinical characteristics of hepatocellular carcinoma in Xiamen.

  • Authors : Zhang Z; Department of Hepatic Oncology, Zhongshan Hospital, Fudan University (Xiamen Branch), Xiamen Clinical Research Center for Cancer Therapy, Clinical Research Center for Precision medicine of abdominal tumor of Fujian Province, Xiamen 361015, China.; Wang M

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/epidemiology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/diagnosis ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology

  • Source: Cancer epidemiology [Cancer Epidemiol] 2024 Dec; Vol. 93, pp. 102691. Date of Electronic Publication: 2024 Oct 31.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101508793 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Camrelizumab plus rivoceranib compared sorafenib as first-line therapeutic options for advanced hepatocellular carcinoma in China: a cost-effectiveness analysis.

  • Authors : Cai H; Department of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, China.; Lin J

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/economics ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/drug therapy

  • Source: BMJ open [BMJ Open] 2024 Dec 11; Vol. 14 (12), pp. e079603. Date of Electronic Publication: 2024 Dec 11.Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  12,673 results for ""Hepatocellular carcinoma""